Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × relatlimab × Clear all

Sponsor

Conditions

Melanoma 4 Advanced Cancer 3 Uveal Melanoma 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Various Advanced Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Paclitaxel 19 pembrolizumab 16 Carboplatin 12 Bevacizumab 7 lenvatinib 6 rucaparib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 Gemcitabine 4 Cisplatin 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Trastuzumab 2 Taxes 2 Radiotherapy, Intensity-Modulated 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡